A NONELECTROSTATIC SPACER FOR AEROSOL DELIVERY

被引:97
作者
BISGAARD, H [1 ]
ANHOJ, J [1 ]
KLUG, B [1 ]
BERG, E [1 ]
机构
[1] ASTRO DRACO AB,DEPT ANALYT CHEM,LUND,SWEDEN
关键词
SPACER; AEROSOL; PRESSURIZED METERED DOSE INHALERS;
D O I
10.1136/adc.73.3.226
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A pear shaped non-electrostatic spacer, composed of steel with a volume of 250 mi and equipped with a facemask containing integrated inlet and outlet valves for inspiration and expiration, was compared with three plastic spacers. The plastic spacers were primed with repeated puffs from a budesonide pressurised metered dose inhaler (p-MDI) to minimise the electrostatic charge on the plastic. The procedure prolonged the half Life (t(1/2)) of the aerosol in the Nebuhaler from nine to 32 seconds. A normal cleaning procedure reduced the aerosol t(1/2) back to baseline. The t(1/2) Of the aerosol in the metal spacer was 27 seconds and independent of the use of p-MDI. In vitro the maximum dose of budesonide from a p-MDI, expressed as a percentage of the nominal dose, was 56% from the non-electrostatic spacer, 61% from the Nebuhaler, 45% from the Babyhaler, and 30% from the AeroChamber. In 124 children, age 6 months to 6 years, suspected to have asthma the non-electrostatic spacer delivered a mean total dose of budesonide aerosol of 39% of the nominal dose, which was significantly higher than the Babyhaler (28%), the Nebuhaler (21%), and the AeroChamber (19%). These differences were most pronounced in children younger than 4 years. The improved dose delivery from the small volume non-electrostatic spacer is probably related to the non-electrostatic spacer material and the valves which assured unidirectional airflow from the spacer without adding any dead space in the inspiratory channel. The non-electrostatic spacer should improve the cost effectiveness of aerosol treatment and, as the counteracting effects of priming and recharging of the plastic from cleaning are avoided, should deliver a more reliable dose.
引用
收藏
页码:226 / 230
页数:5
相关论文
共 11 条
  • [1] INHALED BUDESONIDE FOR TREATMENT OF RECURRENT WHEEZING IN EARLY-CHILDHOOD
    BISGAARD, H
    MUNCK, SL
    NIELSEN, JP
    PETERSEN, W
    OHLSSON, SV
    [J]. LANCET, 1990, 336 (8716) : 649 - 651
  • [2] BISGAARD H, 1995, EUR RESPIR J, V8, P856
  • [3] Bisgaard H, 1994, EUR RESPIR REV, V4, P15
  • [4] RELIABLE SALBUTAMOL ADMINISTRATION IN 6-MONTH-OLD TO 36-MONTH-OLD CHILDREN BY MEANS OF A METERED DOSE INHALER AND AEROCHAMBER WITH MASK
    CONNER, WT
    DOLOVICH, MB
    FRAME, RA
    NEWHOUSE, MT
    [J]. PEDIATRIC PULMONOLOGY, 1989, 6 (04) : 263 - 267
  • [5] USE OF BUDESONIDE IN SEVERE ASTHMATICS AGED 1-3 YEARS
    CONNETT, GJ
    WARDE, C
    WOOLER, E
    LENNEY, W
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (03) : 351 - 355
  • [6] SHORT-TERM EFFECT OF ALBUTEROL, DELIVERED VIA A NEW AUXILIARY DEVICE, IN WHEEZY INFANTS
    KRAEMER, R
    FREY, U
    SOMMER, CW
    RUSSI, E
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (02): : 347 - 351
  • [7] BRONCHODILATOR EFFECT OF FENOTEROL AND IPRATROPIUM BROMIDE IN INFANTS WITH ACUTE WHEEZING - USE OF MDI WITH A SPACER DEVICE
    MALLOL, J
    BARRUETO, L
    GIRARDI, G
    TORO, O
    [J]. PEDIATRIC PULMONOLOGY, 1987, 3 (05) : 352 - 356
  • [8] ARE NEBULIZERS OBSOLETE FOR ADMINISTERING ASTHMA MEDICATIONS TO INFANTS AND CHILDREN
    NEWHOUSE, MT
    [J]. PEDIATRIC PULMONOLOGY, 1993, 15 (05) : 271 - 272
  • [9] INHALED BUDESONIDE FOR CHRONIC WHEEZING UNDER 18 MONTHS OF AGE
    NOBLE, V
    RUGGINS, NR
    EVERARD, ML
    MILNER, AD
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (03) : 285 - 288
  • [10] IMPROVEMENT IN SODIUM CROMOGLYCATE DELIVERY FROM A SPACER DEVICE BY USE OF AN ANTISTATIC LINING, IMMEDIATE INHALATION, AND AVOIDING MULTIPLE ACTUATIONS OF DRUG
    OCALLAGHAN, C
    LYNCH, J
    CANT, M
    ROBERTSON, C
    [J]. THORAX, 1993, 48 (06) : 603 - 606